Published on 28 Apr 2023 on Benzinga via Yahoo Finance
Remember Lucira Health's 30 Minute Home Test Kit? Pfizer Just Bought the Bankrupt Company Via...
Lucira Health Inc (OTC: LHDXQ) has been acquired by Pfizer Inc (NYSE: PFE) for $36.4 million through a bankruptcy auction. According to the SEC document, the asset sale closed on April 20.
Remember Lucira Health's 30 Minute Home Test Kit? Pfizer Just Bought the Bankrupt Company Via...
Lucira Health Inc (OTC: LHDXQ) has been acquired by Pfizer Inc (NYSE: PFE) for $36.4 million thro...
Within Two Years Of Public Debut, COVID-19 Test Maker Files For Bankruptcy
Lucira Health Inc (NASDAQ: LHDX) filed for protection under Chapter 11 of the U.S. Bankruptcy Cod...
Why Cano Health Shares Are Trading Lower By Around 23%? Here Are Other Stocks Moving In Thursday's...
Why Cano Health Shares Are Trading Lower By Around 23%? Here Are Other Stocks Moving In Thursday'...
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.71%
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.71%
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.22% By Investing.com
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.22%
FDA Approval Brings Some Good News For Bankrupt Lucira Health
Friday, the FDA issued an emergency use authorization (EUA) for the first over-the-counter (OTC) ...
Why Fulcrum Therapeutics Shares Are Trading Lower By Over 55%? Here Are Other Stocks Moving In...
Why Fulcrum Therapeutics Shares Are Trading Lower By Over 55%? Here Are Other Stocks Moving In...
Lucira stock more than doubles after hours on FDA OK for COVID-19, flu test
Lucira Health Inc. shares more than doubled in the extended session Friday after the Food and Dru...
At-home Covid test maker falls into Chapter 11 bankruptcy
Delays in winning emergency use authorization for a combined Covid-flu test — making the company...
Two Covid-era biotech IPOs — Spruce and Graphite Bio — see stock head in different directions
It's been an up-and-down week for Bay Area life sciences stocks as health care executives start t...